Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute
- MVT
- Jul 30, 2021
- 0 min read
top of page
Search
Recent Posts
See AllDecember 4, 2025 — Salt Lake City, UT — The Nucleus Institute’s investment committee has unanimously approved and completed an investment in Microvascular Therapeutics Inc. (MVT) through MVT’s conver
Salt Lake City, UT –Wednesday November, 5 th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultr
Phase‑shift microbubble (also known as nanobubble) technology demonstrates robust thrombus resolution in a porcine deep vein thrombosis (DVT) model. Salt Lake City, UT – Microvascular Therapeutics, In
bottom of page
Comments